Consistent with these findings, an increased expression of fatty acid elongase 2 and 5 (ELOVL2 and ELOVL5) and stearoyl-CoA desaturase-1 (SCD1) was described in ccRCC. The gene discussed is ELOVL2; the disease is nonpapillary renal cell carcinoma.